Metronomic chemotherapy in small animal practice: An update
Nenhuma Miniatura disponível
Data
2016-01-01
Autores
Fonseca-Alves, Carlos Eduardo [UNESP]
Calazans, Sabryna Gouveia
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Metronomic chemotherapy can be considered a new chemotherapy modality involving continuous administration of low doses of cytostatic agents which targets endothelial cells. Endothelial cells are vital for the development of new blood vessels and are essential for tumour growth. Furthermore, these cells are genetically stable, divide at a high rate and do not acquire resistance to cytotoxic drugs as tumour cells. Therefore, they are sensitive to low doses of cytostatics. Because of the importance of metronomic chemotherapy in veterinary medicine, this review provides an update of the status of metronomic chemotherapy in small animal practice. In dogs with cancer, metronomic chemotherapy can be considered a good treatment option and a first-line therapy. Further studies evaluating the levels of regulatory T cells Tregs and tumour microvessel density are needed to better understand the role of this therapeutic modality in different canine tumours.
Descrição
Palavras-chave
Angiogenesis, COX-2, Cyclophosphamide, Regulatory T cells, Tumour microenvironment
Como citar
Asian Journal of Animal and Veterinary Advances, v. 11, n. 1, p. 17-23, 2016.